Lv1
98 积分 2024-12-18 加入
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
1小时前
待确认
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
26天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
28天前
已关闭
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
28天前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
Effects of different B-cell-depleting strategies on the lymphatic tissue
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
皖公网安备34019202002308
